期刊文献+

伊马替尼联合高三尖杉酯碱或阿糖胞苷对K562细胞作用的研究 被引量:3

原文传递
导出
摘要 伊马替尼是一种ber/abl酪氨酸激酶活性抑制剂^[1]。近年来研究表明,伊马替尼能够选择性地抑制K562细胞的增殖、诱导K652细胞凋亡。临床和实验研究揭示高三尖杉酯碱治疗慢性粒细胞白血病(CML)有确切的疗效,可以明显地抑制K562细胞增殖、诱导K562细胞凋亡。阿糖胞苷是治疗CML的常用药物,对K562细胞的增殖有一定的抑制作用,亦可诱导K562细胞的凋亡。我们在本研究中探索伊马替尼与高三尖杉酯碱或阿糖胞苷联合应用是否有协同和增强抑制K562细胞增殖、影响K562细胞凋亡的作用,以及对ber/ablmRNA水平的作用。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第11期770-772,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献9

  • 1O'Brien SG, Deininger MW. Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia. Semin Hematol, 2003,40 : 26-30. 被引量:1
  • 2Deininger MW, Goldman JM, Lydon N , et al . The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL- positive cells. Blood, 1997, 90:3691-3698. 被引量:1
  • 3Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the abl protein tyrosine kinase on the growth of Bcr-abl positive cells. Nat Med, 1996, 2: 561-566. 被引量:1
  • 4Wang JY. Regulation of cell death by the Abl tyrosine kinase. Oncogene, 2000, 19:5643-5650. 被引量:1
  • 5陈丽娟,盛瑞兰,朱广荣,汪承亚.GM-CSF与阿糖胞苷、高三尖杉酯碱联合诱导HL-60细胞凋亡的实验研究[J].南京医科大学学报(自然科学版),1998,18(2):98-100. 被引量:1
  • 6Nimmanapalli R, Porosnicu M, Nguyen D, et al. Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand ( TRAIL or apo-2L) -induced apoptosis of Bcr-Ab1-positive human acute leukemia cells. Clin Cancer Res, 2001, 7:350-357. 被引量:1
  • 7Gora-Tybor J, Deininger MW, Golgman JM, et al. The susceptibility of Philadelphia chromosome positive cellsto FAS-mediated apoptosis is not linke to the tyrosinekinase activity of BCR-ABL. Br J Haematol, 1998, 103:716-720. 被引量:1
  • 8Horita M, Andreu EJ , Benito A, et al. Blockade of the Bcr-Abl kinase activity induces apeptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-XL. J Exp Med, 2000, 191:977-984. 被引量:1
  • 9秦亚溱,陈珊珊,常艳,付家瑜,王新娟.STI571诱导K562细胞凋亡机制研究[J].中华血液学杂志,2002,23(6):289-292. 被引量:4

二级参考文献11

  • 1Carroll M,Ohno-Jones S,Tamura S,et al.CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL and TEL-PDGFR fusion proteins[].Blood.1997 被引量:1
  • 2Bass DA,Parce W,Lawrence R,et al.Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation[].J Immunol.1983 被引量:1
  • 3Fennell DA,Cotter FE.Stochastic modeling of apoptosis tolerance distributions measured by multivariate flow analysis of human leukemia cells[].Cytometry.2000 被引量:1
  • 4Sattler M,Verma S,Shrikhande G,et al.The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells[].Journal of Biological Chemistry.2000 被引量:1
  • 5Adams JM,Cory S.The Bcl-2 protein family: arbiters of cell survival[].Science.1998 被引量:1
  • 6Benito A,Silva M,Grilot D,et al.Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL[].Blood.1996 被引量:1
  • 7Kroemer G,Zamzami NA,Susin SA.Mitochondrial control of apoptosis[].Immunology Today.1997 被引量:1
  • 8Amarante-Mendes GP,McGahon AJ,Nishioka WK,et al.Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-XL[].Oncegene.1998 被引量:1
  • 9Amarante-Mendes GP,Kim CN,Linda L,et al.Bcr-abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activition of caspase-3[].Blood.1998 被引量:1
  • 10Druker BJ,Lydon NB.Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia[].The Journal of Clinical Investigation.2000 被引量:1

共引文献3

同被引文献24

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部